MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 74 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,839,311 | -30.3% | 592,758 | -0.4% | 0.00% | – |
| Q2 2023 | $4,075,990 | -1.4% | 595,035 | +12.1% | 0.00% | – |
| Q1 2023 | $4,134,511 | -47.5% | 530,746 | -48.7% | 0.00% | – |
| Q4 2022 | $7,874,462 | +98.9% | 1,034,752 | +113.5% | 0.00% | – |
| Q3 2022 | $3,959,000 | -9.2% | 484,571 | +7.5% | 0.00% | – |
| Q2 2022 | $4,360,000 | -15.8% | 450,864 | +22.0% | 0.00% | – |
| Q1 2022 | $5,181,000 | +27.1% | 369,568 | +85.2% | 0.00% | – |
| Q4 2021 | $4,075,000 | +20.7% | 199,576 | +31.7% | 0.00% | – |
| Q3 2021 | $3,376,000 | – | 151,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $12,029,000 | 7.99% |
| NEA Management Company, LLC | 7,703,205 | $62,935,000 | 3.14% |
| Cormorant Asset Management, LP | 2,993,717 | $24,459,000 | 1.71% |
| Alphabet Inc. | 1,464,015 | $11,961,000 | 0.61% |
| Avoro Capital Advisors LLC | 3,363,333 | $27,478,000 | 0.51% |
| Casdin Capital, LLC | 510,882 | $4,174,000 | 0.27% |
| RTW INVESTMENTS, LP | 1,214,572 | $9,923,000 | 0.23% |
| Woodline Partners LP | 502,411 | $4,105,000 | 0.06% |
| Virtus Investment Advisers, Inc. | 12,638 | $103,000 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $230,000 | 0.04% |